Merck & Co., Inc. (MRK), Monday announced its plan to organize its Human Health business into an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit to ensure strong commercial execution of launches across diverse therapeutic areas.
Concurrently, Jannie Oosthuizen has been appointed as executive vice president and president, Oncology and MSD International. He most recently served as senior vice president and president, Merck Human Health U.S.
Also, Brian Foard will join the company as executive vice president and president, Specialty, Pharma & Infectious Diseases, effective March 2, 2026. He most recently served as executive vice president and head of Specialty Care Business Unit at Sanofi.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.